Wells Fargo & Company Alpha Teknova, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 197 shares of TKNO stock, worth $236. This represents 0.0% of its overall portfolio holdings.

Number of Shares

197

Previous 194 1.55%

Holding current value

$236

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.41 - $3.88 $7 - $11	3 Added 1.55%	197 $0
Q4 2023 Feb 09, 2024	BUY	$1.85 - $3.73 $181 - $365	98 Added 102.08%	194 $0
Q3 2023 Nov 13, 2023	BUY	$1.66 - $3.83 $1 - $3	1 Added 1.05%	96 $0
Q2 2023 Aug 15, 2023	SELL	$1.8 - $3.98 $1,929 - $4,266	-1,072 Reduced 91.86%	95 $0
Q1 2023 May 12, 2023	BUY	$2.74 - $6.25 $3,077 - $7,018	1,123 Added 2552.27%	1,167 $3,000

Q4 2022 Feb 13, 2023	SELL	$3.23 - $5.64 $67 - $118	-21 Reduced 32.31%	44 $0
Q3 2022 Nov 14, 2022	SELL	$3.34 - $9.2 $875 - $2,410	-262 Reduced 80.12%	65 $0
Q2 2022 Aug 12, 2022	SELL	$6.39 - $16.24 $451,958 - $1.15 Million	-70,729 Reduced 99.54%	327 $3,000
Q1 2022 May 16, 2022	BUY	$12.79 - $21.64 $27,933 - $47,261	2,184 Added 3.17%	71,056 $981,000
Q4 2021 Feb 14, 2022	SELL	$17.49 - $26.72 $1.92 Million - $2.94 Million	-110,034 Reduced 61.5%	68,872 $1.41 Million
Q3 2021 Nov 15, 2021	BUY	$17.47 - $27.49 $406,229 - $639,224	23,253 Added 14.94%	178,906 $4.45 Million
Q2 2021 Aug 16, 2021	BUY	$23.73 - $27.98 $3.69 Million - $4.36 Million	155,653 New	155,653 $3.69 Million

Others Institutions Holding TKNO

# of Institutions

Shares Held

6.29M

Call Options Held

Put Options Held

View Full List

About Alpha Teknova, Inc.

Ticker TKNO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 28,080,500
Market Cap $33.7M
Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...

More about TKNO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Alpha Teknova, Inc. Transaction History